AID Genomics is a group of medical technology companies specializing in the diagnosis and therapy of cancer.
Annexon Biosciences is leading the development of therapeutic products that halt the progression of complement-mediated neurodegeneration.
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
Rehovot, IL HQ
South San Francisco, US HQ
Milton, GB HQ
San Jose, US
Latest funding round
Latest funding roundN/A
Latest funding round$ 100m (about 1 year ago)
Latest funding round$ 10m (about 6 years ago)
Total funding raised
Total funding raisedN/A
Total funding raised$ 179m
Total funding raised$ 21.6m